SRXH

SRx Health Solutions Inc. · AMEX · Healthcare · USD · 10-K for 2025, filed 2025-12-05

Figures on this page computed 2026-11-08 13:17 UTC

Last close

0.89USD

Market data, 2026-11-04

SRXH: weekly closes from 13.68 on 2025-11-07 to 0.89 on 2026-11-04, a move of -93.5%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-04

Over that span: -93.5%

Except where said otherwise: 10-K for 2024, filed 2025-03-31

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
The filing itself
-0.5%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
-12.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.29 against 0.52 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.26x

1.26x

n/a

0.37x

0.05x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2025-12-05

Sales0.26x
Its own average over 10 years, 25.4M.
Profit1.26x
Its own average over 10 years, -35.6M.
Free cash flown/a
Its own average over 9 years, -8.2M.
Debt0.37x
Its own average over 9 years, 12.0M.
Price0.05x
Its own average over 2 years, 17. Market data, 2026-11-04

Price is furthest from its own average, at 0.05 times.

The filed years, as a table

Each line is 100 at 2016-08-31, the first year we hold.

Filed year	Sales10-K for 2025, filed 2025-12-05	Shares in issue10-K for 2025, filed 2025-12-05
2016-08-31	100.0	100.0
2017-08-31	3,612.5	4.3
2018-12-31	30,802,083.3	n/a
2019-12-31	32,452,083.3	n/a
2020-12-31	88,729,166.7	11.6
2021-12-31	95,845,833.3	31.1
2022-12-31	113,875,000.0	0.9
2023-12-31	80,400,000.0	1.0
2024-12-31	72,864,583.3	2.3
2025-09-30	13,612,500.0	30.0

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001493152-25-026452
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001493152-25-026452
Reported in: USD

The filing itself

Figures behind the shape

Growth

17.6%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate17.6%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income99.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-1.1%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
The filing itself
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
The filing itself
Return on assets-1.1%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
The filing itself

Margins

37.1%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin37.1%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
Operating margin-17.1%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
Net margin-0.5%
Net Income / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
Free cash flow margin-12.6%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself

Price

0.001x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
The filing itself
Price to bookn/a10-Q for 2024, filed 2026-08-13
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2024
Accession
0001493152-26-037793
Reported in
USD
- computed
- 10-Q for 2024, filed 2026-08-13
- computed
- 10-K for 2024, filed 2025-03-31
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2025-05-15
- 10-K for 2024, filed 2025-03-31
The filing itself
Price to sales ratio0.001x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- computed
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself

Safety

2.10

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-Q for 2024, filed 2026-08-13
The filing itself
Current ratio2.1010-Q for 2024, filed 2025-05-15
Current Assets / Current Liabilities
Source
computed
Fiscal year
2024
Accession
0001641172-25-011011
Reported in
USD
- 10-Q for 2024, filed 2025-05-15
- 10-Q for 2024, filed 2025-05-15
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
Altman Z-Score-26.92
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2024, filed 2025-03-31
- Computed from the 10-K for 2024, filed 2025-03-31
- Computed from the 10-K for 2024, filed 2025-03-31
- Computed from the 10-K for 2024, filed 2025-03-31
- Computed from the 10-K for 2024, filed 2025-03-31

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2024
Accession
0001641172-25-001558
Reported in
USD
- 10-K for 2024, filed 2025-03-31
- Computed from the 10-K for 2024, filed 2025-03-31
- 10-K for 2024, filed 2025-03-31
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.